June 23, 2020 8:43 AM EDT


Send to a Friend

Oppenheimer analyst Jay Olson raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $89.00 (from $80.00) while maintaining an ...

This is a premium only article. To continue reading this article and more like it please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE





Source link